another news portal
A pioneering study presented today at ESCMID Global 2025 has demonstrated that an AI-powered lung ultrasound outperforms human experts by 9% in diagnosing pulmonary tuberculosis
The measles outbreak in West Texas didn’t happen just by chance
Despite decades of efforts focused on mosquito eradication, drug therapies, and vaccines, malaria remains hard to beat, especially in Africa.
A major study presented today at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) face a 2.7-fold higher
A longstanding mystery in Parkinson’s disease research has been why some individuals carrying pathogenic variants that increase their risk of PD go on to develop
In his first network TV interview since becoming Health and Human Services Secretary, Robert F. Kennedy Jr. sat down with Dr. Jon LaPook. Kennedy said
World Health Organization members are finalizing plans for nations to share life-saving technology with developing countries as part of a new pandemic preparation agreement.
Officials for the Centers for Disease Control and Prevention denied Milwaukee Public Schools officials’ request for help with a lead contamination problem in several schools
It’s becoming increasingly commonplace for people to develop intimate, long-term relationships with artificial intelligence (AI) technologies.
As scientists seek to unravel the intricate potential connections between nutrition and the aging brain, a new study from researchers at the Jean Mayer USDA
Traumatically injured women are considerably less likely to receive whole blood transfusions within the first four hours of injury compared to men, despite whole blood
Researchers at Moffitt Cancer Center have found that tapping into the body’s own immune system and activating a type of immune cell known as B
A key program using traditional medicine and foods to tackle chronic disease in Native American and Alaska Native communities has been gutted in the federal
A pioneering study presented today at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection
